Journals / Türk Geriatri Dergisi / 2016 / Cilt: 19 - Sayı: 4

GUİLLAİN-BARRÉ SENDROMLU BİR KADINDA MEME KANSERİ-PARANEOPLASTİK NÖROLOJİK SENDROMLAR İÇİN BİR HATIRLATMA

BREAST CANCER IN A WOMAN WITH GUILLAIN-BARRÉ SYNDROME: A REMINDER TO CONSIDER PARANEOPLASTIC NEUROLOGICAL SYNDROME

Pages
260–263
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Because paraneoplastic neurological syndrome occurs at an early stage of cancer before metastasis, it is important to considerparaneoplastic neurological syndrome when evaluating Guillain-Barré syndrome patients

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A72-year-old woman was referred to us for Guillain-Barré syndrome rehabilitation, duringwhich her functional status improved (Hughes score 3-2, Functional AmbulationClassification Scale 2-4, Functional Independence Measure score 99-120).
📊
Key Findings & Data:Despite her improvement, discharge was postponed because of a bloody discharge from her left nipple, which started 1 day before the last visit.
💡
Conclusion & Impact:Because paraneoplastic neurological syndrome occurs at an early stage of cancer before metastasis, it is important to considerparaneoplastic neurological syndrome when evaluating Guillain-Barré syndrome patients
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A72-year-old woman was referred to us for Guillain-Barré syndrome rehabilitation, duringwhich her functional status improved (Hughes score 3-2, Functional AmbulationClassification Scale 2-4, Functional Independence Measure score 99-120). Despite her improvement, discharge was postponed because of a bloody discharge from her left nipple, which started 1 day before the last visit. The final diagnosis, after an excisional biopsy, was invasive ductalcarcinoma with apocrine features. Guillain-Barré syndrome is an acute, rapidly progressinginflammatory polyneuropathy, with patients typically showing symmetrical, ascending weaknesswith a severe loss of reflexes. The current literature describes Guillain-Barré syndrome as a probable paraneoplastic neurological syndrome and cancer precursor. Guillain-Barré syndrome withthis etiology, i.e., paraneoplastic neurological syndrome, may result from remote effects withimmunological mechanisms that are not directly caused by the tumor or metastases infiltration.Guillain-Barré syndrome may develop as a paraneoplastic neurological syndrome, may be secondary to treatment, or may occur coincidentally with cancer. Because paraneoplastic neurological syndrome occurs at an early stage of cancer before metastasis, it is important to considerparaneoplastic neurological syndrome when evaluating Guillain-Barré syndrome patients

Özet

Guillain-Barré sendromu saptanan 72 yaşındaki kadın hasta, rehabilitasyon amacıyla tarafımızayönlendirildi. Rehabilitasyon sürecinde, fonksiyonel düzeyinde bir kazanım elde edildi (Hughesskoru 3'ten 2'ye, Functional Ambulation Classification düzeyi 2'den 4'de, Functional Independence Measure skoru 99'dan 120'ye değişim gösterdi). Bu gelişmeye rağmen, son vizitten bir günönce sol meme ucundan gelen kanlı akıntı şikayeti nedeniyle taburcu işlemi ertelendi. Eksizyonelbiyopsi sonucu nihai tanı apokrin özellik taşıyan invasiv ductal carcinoma olarak tanımlandı. Guillain-Barré sendromu akut, hızlı progresyon gösteren bir inflamatuar polinöropati dir. Bu hastalarda çoğunlukla reflex kaybının eşlik ettiği, simetrik, asendan güçsüzlük saptanır. Güncel literaturde, Guillain-Barré sendromu muhtemel paraneoplastik sendrom ve kanser öncüsü olarak tanımlanır. Bu tür bir Guillain-Barré sendromu, yani paraneoplastik sendrom; tümör veya metastaz infiltrasonunun doğrudan etkisi dışında, immünolojik mekanizmalara bağlı oluşan uzak bir etkidenkaynaklanabilir. Guillain-Barré sendromu; bir paraneoplastik sendrom olabilir, kanserle birlikte tesadüfi olarak veya tedaviye ikincil olarak gelişebilir. Bununla birlikte, paraneoplastik sendromunmetastazlar oluşmadan önce, kanserin erken evresinde ortaya çıkması, Guillain-Barré sendromuolarak değerlendirilen tüm hastalarda paraneoplastik sendromu düşünmeyi elzem kılar

🔖

Cite This Article

TUNA, F., TUNA, H., DÜZCE, E., TAŞTEKİN, E., ÖZDEMİR, H. (2022). GUİLLAİN-BARRÉ SENDROMLU BİR KADINDA MEME KANSERİ-PARANEOPLASTİK NÖROLOJİK SENDROMLAR İÇİN BİR HATIRLATMA. Türk Geriatri Dergisi, Cilt: 19 - Sayı: 4, 260–263. https://ajindex.com/articles/623776

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Hughes RA, Wijdicks EF, Benson E, et al. Supportive care forpatients with Guillain-Barre syndrome. Archives of neurology2005
  2. (PMID:16087757). Graus F, Delattre JY, Antoine JC, et al. Recommended diag-nostic criteria for paraneoplastic neurological syndromes. Jour-nal of neurology, neurosurgery, and psychiatry 2004
  3. (PMID: 15258215). Watanuki S, Kinoshita K, Oda A, et al. Occam's Razor or Hic-kam's Dictum: A Paraneoplastic or Coincidental Occurrence ofLung Cancer and Guillain-Barré Syndrome. Internal medicine(Tokyo, Japan) 2014
  4. (PMID:25030575). Giometto B, Grisold W, Vitaliani R, et al. Paraneoplastic ne-urologic syndrome in the PNS Euronetwork database: a Euro-pean study from 20 centers. Archives of neurology2010
  5. (PMID:20212230). Adıgüzel E, Demir Y, Alaca R, Tan AK. Paraneoplastic Neuro-logic Syndrome: Three Case Reports. Turk J Phys Med Rehab2015
  6. DOI: 10.5152/tftrd.2015.90907. Vigliani MC, Magistrello M, Polo P, et al. Risk of cancer in pa-tients with Guillain-Barre syndrome (GBS). A population-ba-sed study. J Neurol 2004
  7. (PMID:15015013) Peterson K, Forsyth PA, Posner JB. Paraneoplastic sensorimo- tor neuropathy associated with breast cancer. Journal of neuro- oncology 1994
  8. (PMID:7861192). Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collec- tion, analysis, and presentation of immunization safety data. Vaccine 2011
  9. (PMID:20600491). Fokke C, van den Berg B, Drenthen J, et al. Diagnosis of Guil- lain-Barré syndrome and validation of Brighton criteria. Brain 2013:awt285. (PMID:24163275). Hughes RA, Cornblath DR. Guillain-Barré syndrome. The Lancet 2005
  10. (PMID:16271648). Jung BF, Herrmann D, Griggs J, Oaklander AL, Dworkin RH. Neuropathic pain associated with non-surgical treatment of breast cancer. Pain 2005
  11. (PMID:16213086). Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. The New England journal of medicine 2003
  12. (PMID:14561798). Honnorat J, Antoine JC. Paraneoplastic neurological syndro- mes. Orphanet journal of rare diseases 2007
  13. (PMID:17480225). Graus F, Dalmau J. Paraneoplastic neuropathies. Curr Opin Neurol 2013
  14. (PMID: 23892629). Rojas-Marcos I, Rousseau A, Keime-Guibert F, et al. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer. Medicine 2003
  15. (PMID:12792307).